This contract expires in 117 days (Nov 2, 2026).
NANOHMICS INC - MEDICAL & RESEARCH DEVELOPMENT CONTRACT FOR DHA STTR PH II A2-9110 PROPOSAL TITLED INGESTIBLE CAPSULE FOR VITAL SIGN MONITORING.
Key Details
Description
MEDICAL & RESEARCH DEVELOPMENT CONTRACT FOR DHA STTR PH II A2-9110 PROPOSAL TITLED INGESTIBLE CAPSULE FOR VITAL SIGN MONITORING.
Context & Analysis
On Nov 20, 2025, Department of Defense obligated $1,099,996.57 to NANOHMICS INC for medical & research development contract for dha sttr ph ii a2-9110 proposal titled ingestible capsule for vital sign monitoring.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 2 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in AUSTIN, TX. The contract is scheduled through Nov 2, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Defense under NAICS 541715 — related awards are listed below.
Contractor Information
Similar Awards
NAVAL NUCLEAR LABORATORY
FLUOR MARINE PROPULSION, LLC
$14.2B
NAVAL NUCLEAR LABORATORY
FLUOR MARINE PROPULSION, LLC
$13.6B
NEXT GENERATION OVERHEAD PERSISTENT INFRARED GEOSYNCHRONOUS EARTH ORBIT SPACE VEHICLE 1-3 PHASE 1
LOCKHEED MARTIN CORP
$6.3B
NEXT GENERATION OVERHEAD PERSISTENT INFRARED GEOSYNCHRONOUS EARTH ORBIT SPACE VEHICLE 1-3 PHASE 1
LOCKHEED MARTIN CORP
$6.3B
DESIGN, DEVELOPMENT, AND DEVELOPMENTAL TESTING OF THE NEXT GENERATION INTERCEPTOR (NGI) ALL-UP-ROUND (AUR)
LOCKHEED MARTIN CORPORATION
$4.6B
Stay Updated
Get notified about new opportunities matching your interests.